Medtronic To Spend $3.7 Billion On Developers Of Artificial Pancreas
By BridgeNews Medical technology company Medtronic Inc., Minneapolis, will spend $3.7 billion to acquire MiniMed Inc. and Medical Research Group, two companies that are working to develop an "artificial pancreas" for diabetics. MiniMed makes insulin ...